Suppr超能文献

尿激酶成功治疗一名置有中心静脉导管婴儿的上腔静脉综合征

Successful treatment of superior vena cava syndrome with urokinase in an infant with a central venous catheter.

作者信息

Caglar M K, Tolboom J

机构信息

Department of Pediatrics, University Hospital Nijmegen, The Netherlands.

出版信息

Helv Paediatr Acta. 1989 Jun;43(5-6):483-6.

PMID:2501237
Abstract

An infant with superior vena cava syndrome due to thrombus formation in the superior vena cava, sourced from a central venous line, was treated with urokinase. It was used in a loading dose of 250,000 units/1.73 m2/15 min, followed by continuous infusion of 125,000 units/1.73 m2/h for three days. After two days of urokinase treatment, the clinical signs of superior vena cava syndrome completely disappeared. No bleeding complication was observed.

摘要

一名因上腔静脉内血栓形成导致上腔静脉综合征的婴儿,血栓源于中心静脉导管,接受了尿激酶治疗。尿激酶的负荷剂量为250,000单位/1.73平方米/15分钟,随后以125,000单位/1.73平方米/小时的速度持续输注三天。尿激酶治疗两天后,上腔静脉综合征的临床症状完全消失。未观察到出血并发症。

相似文献

2
Successful treatment of superior vena cava syndrome with urokinase in an infant.
JPEN J Parenter Enteral Nutr. 1988 Jan-Feb;12(1):81-3. doi: 10.1177/014860718801200181.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验